Pet Vaccines Market
Pet Vaccines Market Forecasts to 2034 - Global Analysis By Vaccine Type (Core Vaccines, Non-Core Vaccines, Combination Vaccines, Emerging and Therapeutic Vaccines), Animal Type, Disease Indication, Route of Administration, Distribution Channel, Vaccine Valency, End User, and By Geography
Market Dynamics:
Driver:
Routine preventive care and risk-based vaccination protocols
Routine preventive-care visits remain the primary channel for pet vaccination, while risk-based protocols increasingly shape product selection by age, lifestyle, travel and exposure. Veterinarians recommend core vaccines for population health and non-core vaccines for animals at higher risk, supporting repeat demand and predictable scheduling. Owner awareness, reminder systems and clinic access improve compliance, and continued innovation in combination and next-generation vaccines sustains interest. As preventive care becomes more personalized, demand is likely to remain steady across dogs, cats and other companion animals.
Restraint:
Variable vaccine access and owner concerns about cost or adverse events
Vaccine access varies by geography, clinic capacity and distribution reach, and owners may delay or decline vaccination because of cost, convenience or concern about adverse events. Differences in professional recommendations and uneven owner awareness can also reduce confidence, especially where product information is limited. In remote or price-sensitive households, access to trained providers and affordable products remains constrained. Suppliers and clinics need clear safety communication, transparent pricing and reliable supply to address hesitancy and support consistent vaccination uptake.
Opportunity:
Combination products and improved preventive-care delivery
Combination vaccines and improved delivery models can reduce visit burden, simplify protocols and improve compliance. Practitioner partnerships, reminder systems, online education and clinic-led follow-up can help owners understand timing and risk-based recommendations. Tailored formats and clearer labeling can differentiate products in competitive markets. There is also scope to extend preventive care to underserved life stages and multi-pet households through coordinated veterinary, retail and digital channels. Providers that combine credible evidence with convenient access can strengthen retention and broaden adoption beyond major urban centers.
Threat:
Pathogen shifts, safety scrutiny and manufacturing disruption
Pathogen evolution, emerging disease patterns and changes in circulating strains can reduce the fit of existing vaccines and require ongoing surveillance. Safety scrutiny and adverse-event reporting may increase regulatory and reputational pressure, while manufacturing disruption, ingredient shortages or distribution constraints can affect supply. Competition from lower-priced substitutes and inconsistent product claims can further complicate purchasing decisions. Companies need robust pharmacovigilance, traceable sourcing, clear evidence and resilient manufacturing to maintain trust and protect market position during disruption.
Covid-19 Impact:
The COVID-19 pandemic disrupted veterinary appointments, specialist retail, travel and pet-care supply chains, while shifting more purchasing and advice-seeking online. Some owners postponed non-urgent services, but increased time at home and heightened attention to animal wellbeing supported demand for home-use products and digital support. Providers responded with e-commerce, teleconsultation and flexible scheduling. As restrictions eased, in-person services recovered, but demand for convenience and clear product information remained. The effect varied by market, depending on clinical need, discretionary spending and reliance on in-person experiences where available.
The Core Vaccines segment is expected to be the largest during the forecast period
The Core Vaccines segment is expected to account for a leading share of the pet vaccines market during the forecast period. Its position reflects the relevance of this group to the addressable companion-animal population and the breadth of use across the market's principal vaccine type applications. Established product availability, owner familiarity and professional recommendations support demand, while a wide range of care needs encourages repeat purchasing or service use. Market participants are expected to prioritize this segment through targeted product development, broader distribution and clearer use guidance.
The Other Companion Animals segment is expected to have the highest CAGR during the forecast period
The Other Companion Animals segment is expected to have the highest CAGR during the forecast period as providers expand targeted solutions and improve access through veterinary, specialist retail and digital channels. Demand is supported by growing awareness of the relevant need, improved product formulation or service delivery, and increased owner willingness to invest in tailored companion-animal care. As evidence, convenience and availability improve, this segment may attract new entrants and encourage established providers to broaden their portfolios.
Region with largest share:
North America is expected to account for a leading share of the pet vaccines market, supported by high companion-animal ownership, comparatively developed veterinary infrastructure, established pet specialty retail and relatively high per-pet expenditure. The United States represents a major demand center because owners have access to veterinary clinics, online pet-care platforms and a broad selection of specialized products and services. Canada contributes through a mature pet-care ecosystem and established companion-animal health providers. Market adoption is also supported by insurance availability, consumer awareness and product innovation, although adoption differs by income, geography and veterinary access.
Region with highest CAGR:
Asia Pacific is expected to exhibit strong growth in the pet vaccines market as pet ownership, urban household formation, veterinary service availability and organized pet retail expand across major markets. China, Japan, South Korea, India and Australia offer different adoption pathways, reflecting differences in purchasing power, veterinary infrastructure, product regulation and the role of digital commerce. Growing awareness of preventive care and rising demand for premium companion-animal products are likely to support market development. Expansion will depend on localized products, professional education and compliance with national animal-health and consumer-protection requirements.
Key players in the market
Some of the key players in the Global Pet Vaccines Market include Zoetis Inc., Merck Animal Health, Boehringer Ingelheim Animal Health, Elanco Animal Health, Ceva Santé Animale, Virbac, Vaxxinova, Bioveta, a.s., Indian Immunologicals Limited, Hester Biosciences Limited, Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, Vetoquinol, HIPRA, Bimeda, CZ Veterinaria S.A., Ourofino Saúde Animal.
Key Developments:
In June 2026, Elanco Animal Health announced USDA approval of a low-volume combination vaccine designed to protect dogs against Lyme disease and leptospirosis in a single dose.
In March 2026, Merck Animal Health announced Canadian approval of its RNA-particle rabies vaccine for dogs and cats, adding a next-generation companion-animal immunization option.
In January 2026, Virbac announced the introduction of Canixin L, an L2 leptospirosis vaccine for dogs designed to reduce infection and associated clinical signs and shedding.
Vaccine Types Covered:
• Core Vaccines
• Non-Core Vaccines
• Combination Vaccines
• Emerging and Therapeutic Vaccines
Animal Types Covered:
• Dogs
• Cats
• Rabbits and Ferrets
• Other Companion Animals
Disease Indications Covered:
• Viral Diseases
• Bacterial Diseases
• Vector-Borne Diseases
• Fungal and Other Infections
Route of Administration Covered:
• Injectable
• Intranasal
• Oral
• Other Routes
Distribution Channels Covered:
• Veterinary Hospitals and Clinics
• Specialty Veterinary Distributors
• Government and Public Procurement
• Veterinary Pharmacies
Vaccine Valencies Covered:
• Monovalent Vaccines
• Bivalent Vaccines
• Multivalent Combination Vaccines
End Users Covered:
• General Veterinary Practices
• Specialty and Emergency Hospitals
• Shelters and Animal Welfare Organizations
• Government and Institutional Programs
Regions Covered:
• North America
o United States
o Canada
o Mexico
• Europe
o United Kingdom
o Germany
o France
o Italy
o Spain
o Netherlands
o Belgium
o Sweden
o Switzerland
o Poland
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Thailand
o Malaysia
o Singapore
o Vietnam
o Rest of Asia Pacific
• South America
o Brazil
o Argentina
o Colombia
o Chile
o Peru
o Rest of South America
• Rest of the World (RoW)
o Middle East
§ Saudi Arabia
§ United Arab Emirates
§ Qatar
§ Israel
§ Rest of Middle East
o Africa
§ South Africa
§ Egypt
§ Morocco
§ Rest of Africa
What our report offers:
• Market share assessments for regional and country-level segments
• Strategic recommendations for new entrants
• Covers market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032, and 2034
• Market trends, including drivers, constraints, opportunities, threats, challenges, investment opportunities, and recommendations
• Strategic recommendations for key business segments based on market estimations
• Competitive landscape mapping and assessment of key industry trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends and assessment of the latest technological advancements
Free Customization Offerings:
All customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, forecasts, and CAGR of any prominent country as per the client's interest (subject to feasibility assessment)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations
2 Research Framework
2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
2.4.1 Data Collection (Primary and Secondary)
2.4.2 Data Modeling and Estimation Techniques
2.4.3 Data Validation and Triangulation
2.4.4 Analytical and Forecasting Approach
3 Market Dynamics and Trend Analysis
3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook
4 Competitive and Strategic Assessment
4.1 Porter's Five Forces Analysis
4.1.1 Supplier Bargaining Power
4.1.2 Buyer Bargaining Power
4.1.3 Threat of Substitutes
4.1.4 Threat of New Entrants
4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison
5 Global Pet Vaccines Market, By Vaccine Type
5.1 Core Vaccines
5.2 Non-Core Vaccines
5.3 Combination Vaccines
5.4 Emerging and Therapeutic Vaccines
6 Global Pet Vaccines Market, By Animal Type
6.1 Dogs
6.2 Cats
6.3 Rabbits and Ferrets
6.4 Other Companion Animals
7 Global Pet Vaccines Market, By Disease Indication
7.1 Viral Diseases
7.2 Bacterial Diseases
7.3 Vector-Borne Diseases
7.4 Fungal and Other Infections
8 Global Pet Vaccines Market, By Route of Administration
8.1 Injectable
8.2 Intranasal
8.3 Oral
8.4 Other Routes
9 Global Pet Vaccines Market, By Distribution Channel
9.1 Veterinary Hospitals and Clinics
9.2 Specialty Veterinary Distributors
9.3 Government and Public Procurement
9.4 Veterinary Pharmacies
10 Global Pet Vaccines Market, By Vaccine Valency
10.1 Monovalent Vaccines
10.2 Bivalent Vaccines
10.3 Multivalent Combination Vaccines
11 Global Pet Vaccines Market, By End User
11.1 General Veterinary Practices
11.2 Specialty and Emergency Hospitals
11.3 Shelters and Animal Welfare Organizations
11.4 Government and Institutional Programs
12 Global Pet Vaccines Market, By Geography
12.1 North America
12.1.1 United States
12.1.2 Canada
12.1.3 Mexico
12.2 Europe
12.2.1 United Kingdom
12.2.2 Germany
12.2.3 France
12.2.4 Italy
12.2.5 Spain
12.2.6 Netherlands
12.2.7 Belgium
12.2.8 Sweden
12.2.9 Switzerland
12.2.10 Poland
12.2.11 Rest of Europe
12.3 Asia Pacific
12.3.1 China
12.3.2 Japan
12.3.3 India
12.3.4 South Korea
12.3.5 Australia
12.3.6 Indonesia
12.3.7 Thailand
12.3.8 Malaysia
12.3.9 Singapore
12.3.10 Vietnam
12.3.11 Rest of Asia Pacific
12.4 South America
12.4.1 Brazil
12.4.2 Argentina
12.4.3 Colombia
12.4.4 Chile
12.4.5 Peru
12.4.6 Rest of South America
12.5 Rest of the World (RoW)
12.5.1 Middle East
12.5.1.1 Saudi Arabia
12.5.1.2 United Arab Emirates
12.5.1.3 Qatar
12.5.1.4 Israel
12.5.1.5 Rest of Middle East
12.5.2 Africa
12.5.2.1 South Africa
12.5.2.2 Egypt
12.5.2.3 Morocco
12.5.2.4 Rest of Africa
13 Strategic Market Intelligence
13.1 Industry Value Network and Supply Chain Assessment
13.2 White-Space and Opportunity Mapping
13.3 Product Evolution and Market Life Cycle Analysis
13.4 Channel, Distributor, and Go-to-Market Assessment
14 Industry Developments and Strategic Initiatives
14.1 Mergers and Acquisitions
14.2 Partnerships, Alliances, and Joint Ventures
14.3 New Product Launches and Certifications
14.4 Capacity Expansion and Investments
14.5 Other Strategic Initiatives
15 Company Profiles
15.1 Zoetis Inc.
15.2 Merck Animal Health
15.3 Boehringer Ingelheim Animal Health
15.4 Elanco Animal Health
15.5 Ceva Santé Animale
15.6 Virbac
15.7 Vaxxinova
15.8 Bioveta, a.s.
15.9 Indian Immunologicals Limited
15.10 Hester Biosciences Limited
15.11 Phibro Animal Health Corporation
15.12 Dechra Pharmaceuticals PLC
15.13 Vetoquinol
15.14 HIPRA
15.15 Bimeda
15.16 CZ Veterinaria S.A.
15.17 Ourofino Saúde Animal
List of Tables
1 Global Pet Vaccines Market Outlook, By Region (2023–2034) ($MN)
2 Global Pet Vaccines Market Outlook, By Vaccine Type (2023–2034) ($MN)
3 Global Pet Vaccines Market Outlook, By Core Vaccines (2023–2034) ($MN)
4 Global Pet Vaccines Market Outlook, By Non-Core Vaccines (2023–2034) ($MN)
5 Global Pet Vaccines Market Outlook, By Combination Vaccines (2023–2034) ($MN)
6 Global Pet Vaccines Market Outlook, By Emerging and Therapeutic Vaccines (2023–2034) ($MN)
7 Global Pet Vaccines Market Outlook, By Animal Type (2023–2034) ($MN)
8 Global Pet Vaccines Market Outlook, By Dogs (2023–2034) ($MN)
9 Global Pet Vaccines Market Outlook, By Cats (2023–2034) ($MN)
10 Global Pet Vaccines Market Outlook, By Rabbits and Ferrets (2023–2034) ($MN)
11 Global Pet Vaccines Market Outlook, By Other Companion Animals (2023–2034) ($MN)
12 Global Pet Vaccines Market Outlook, By Disease Indication (2023–2034) ($MN)
13 Global Pet Vaccines Market Outlook, By Viral Diseases (2023–2034) ($MN)
14 Global Pet Vaccines Market Outlook, By Bacterial Diseases (2023–2034) ($MN)
15 Global Pet Vaccines Market Outlook, By Vector-Borne Diseases (2023–2034) ($MN)
16 Global Pet Vaccines Market Outlook, By Fungal and Other Infections (2023–2034) ($MN)
17 Global Pet Vaccines Market Outlook, By Route of Administration (2023–2034) ($MN)
18 Global Pet Vaccines Market Outlook, By Injectable (2023–2034) ($MN)
19 Global Pet Vaccines Market Outlook, By Intranasal (2023–2034) ($MN)
20 Global Pet Vaccines Market Outlook, By Oral (2023–2034) ($MN)
21 Global Pet Vaccines Market Outlook, By Other Routes (2023–2034) ($MN)
22 Global Pet Vaccines Market Outlook, By Distribution Channel (2023–2034) ($MN)
23 Global Pet Vaccines Market Outlook, By Veterinary Hospitals and Clinics (2023–2034) ($MN)
24 Global Pet Vaccines Market Outlook, By Specialty Veterinary Distributors (2023–2034) ($MN)
25 Global Pet Vaccines Market Outlook, By Government and Public Procurement (2023–2034) ($MN)
26 Global Pet Vaccines Market Outlook, By Veterinary Pharmacies (2023–2034) ($MN)
27 Global Pet Vaccines Market Outlook, By Vaccine Valency (2023–2034) ($MN)
28 Global Pet Vaccines Market Outlook, By Monovalent Vaccines (2023–2034) ($MN)
29 Global Pet Vaccines Market Outlook, By Bivalent Vaccines (2023–2034) ($MN)
30 Global Pet Vaccines Market Outlook, By Multivalent Combination Vaccines (2023–2034) ($MN)
31 Global Pet Vaccines Market Outlook, By End User (2023–2034) ($MN)
32 Global Pet Vaccines Market Outlook, By General Veterinary Practices (2023–2034) ($MN)
33 Global Pet Vaccines Market Outlook, By Specialty and Emergency Hospitals (2023–2034) ($MN)
34 Global Pet Vaccines Market Outlook, By Shelters and Animal Welfare Organizations (2023–2034) ($MN)
35 Global Pet Vaccines Market Outlook, By Government and Institutional Programs (2023–2034) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY

We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.